Synaptotagmin I increases the probability of vesicle fusion at low [Ca2+] in pituitary cells

Am J Physiol Cell Physiol. 2003 Feb;284(2):C547-54. doi: 10.1152/ajpcell.00333.2002. Epub 2002 Oct 16.

Abstract

Synaptotagmin I (Syt I), a low-affinity Ca(2+)-binding protein, is thought to serve as the Ca(2+) sensor in the release of neurotransmitter. However, functional studies on the calyx of Held synapse revealed that the rapid release of neurotransmitter requires only approximately micromolar [Ca(2+)], suggesting that Syt I may play a more complex role in determining the high-affinity Ca(2+) dependence of exocytosis. Here we tested this hypothesis by studying pituitary cells, which possess high- and low-affinity Ca(2+)-dependent exocytic pathways and express Syt I. Using patch-clamp capacitance measurements to monitor secretion and the acute antisense deletion of Syt I from differentiated cells, we have shown that the rapid and the most Ca(2+)-sensitive pathway of exocytosis in rat melanotrophs requires Syt I. Furthermore, stimulation of the Ca(2+)-dependent exocytosis by cytosol dialysis with solutions containing 1 microM [Ca(2+)] was completely abolished in the absence of Syt I. Similar results were obtained by the preinjection of antibodies against the CAPS (Ca(2+)-dependent activator protein for secretion) protein. These results indicate that synaptotagmin I and CAPS proteins increase the probability of vesicle fusion at low cytosolic [Ca(2+)].

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / deficiency*
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Calcium-Binding Proteins / antagonists & inhibitors
  • Calcium-Binding Proteins / metabolism
  • Cells, Cultured
  • DNA, Complementary / genetics
  • Endocytosis / drug effects
  • Endocytosis / genetics
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Exocytosis / drug effects
  • Exocytosis / genetics*
  • Male
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Membrane Proteins / drug effects
  • Membrane Proteins / metabolism
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Oligonucleotides, Antisense
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism*
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • RNA, Messenger / genetics
  • Rats
  • SNARE Proteins
  • Secretory Vesicles / drug effects
  • Secretory Vesicles / metabolism*
  • Synaptotagmin I
  • Synaptotagmins
  • Vesicular Transport Proteins*

Substances

  • CADPS protein, human
  • Calcium-Binding Proteins
  • DNA, Complementary
  • Membrane Glycoproteins
  • Membrane Proteins
  • Nerve Tissue Proteins
  • Oligonucleotides, Antisense
  • Protein Isoforms
  • RNA, Messenger
  • SNARE Proteins
  • Synaptotagmin I
  • Syt1 protein, rat
  • Vesicular Transport Proteins
  • Synaptotagmins
  • Calcium